CODI RHEAR: Open Payments
NPI 1235589318 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$700 in 12 payments from 9 companies in 2025. Trend: 2023 $4,656 · 2024 $1,923 · 2025 $700
Food & beverage: $700
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $177 |
| Novocure Inc. | 1 | $136 |
| GENZYME CORPORATION | 1 | $119 |
| PharmaEssentia USA Corporation | 1 | $111 |
| Gilead Sciences, Inc. | 1 | $67 |
| Merck Sharp & Dohme LLC | 1 | $26 |
| Daiichi Sankyo Inc. | 1 | $24 |
| TAIHO ONCOLOGY, INC. | 1 | $21 |
| UROGEN PHARMA, INC. | 1 | $18 |
Products named: CREON, Optune Lua (NovoTTF-200T), BESREMI, Trodelvy, KEYTRUDA, Enhertu, EPKINLY, LONSURF.
Industry payments across FL — which companies pay providers there.
